Recognizing The Month Of March 2025 As Kidney Month In Delaware.
Summary
Senate Concurrent Resolution 28 recognizes March 2025 as Kidney Month in Delaware. The resolution is primarily commemorative and educational: it highlights the prevalence of chronic kidney disease and end-stage renal disease, notes the role of diabetes and hypertension as leading causes of kidney failure, and emphasizes the importance of early detection, organ donation, and healthy lifestyle choices in preventing or slowing kidney disease.
The resolution also points to Delaware-specific data, including the number of residents living with ESRD, those on dialysis or living with transplants, and the limited number of kidney transplants performed relative to the waiting list. It references the state’s Chronic Renal Disease Program, administered by the Division of Medicaid & Medical Assistance, as an existing support program for eligible residents with ESRD. The measure does not create new benefits, mandates, or regulatory requirements; instead, it serves as a formal legislative recognition and public awareness statement.
Impact
SCR 28 does not amend Delaware statutes or appropriate funds. Its legal effect is limited to a legislative declaration recognizing March 2025 as Kidney Month in Delaware and encouraging public awareness of kidney disease, prevention, screening, and organ donation. The resolution also indirectly highlights existing state support through the Chronic Renal Disease Program, but it does not change that program’s eligibility, administration, or funding.
Sentiment
The general sentiment around the resolution is strongly supportive and noncontroversial. It received unanimous support in the Senate Third Reading vote, with 19 yeas and 0 nays, indicating broad agreement with the public-health message and the symbolic recognition of Kidney Month. No committee opposition or floor debate is reflected in the available record.
Contention
There is no notable policy contention evident in the bill text or voting history. Because the resolution is honorary and awareness-focused, it does not appear to have generated disagreement over spending, regulation, or program changes. The only substantive policy references are to kidney disease prevalence, transplant access, and the existing state renal disease assistance program, but these are presented as background rather than disputed issues.